Embolex and Enterococcal sepsis - a phase IV clinical study of FDA data

Summary:

Enterococcal sepsis is reported as a side effect among people who take Embolex (dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride), especially for people who are male, 40-49 old, also take Celebrex, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Enterococcal sepsis when taking Embolex. It is created by eHealthMe based on reports of 1,159 people who have side effects when taking Embolex from the FDA, and is updated regularly.

What is Embolex?

Embolex has active ingredients of dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride. eHealthMe is studying from 1,161 Embolex users. Check the latest studies of Embolex.

What is Enterococcal sepsis?

Enterococcal sepsis is found to be associated with 191 drugs and 336 conditions by eHealthMe. Check the latest studies of Enterococcal sepsis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

1,159 people reported to have side effects when taking Embolex.
Among them, 19 people (1.64%) have Enterococcal sepsis.

Could Embolex cause Enterococcal sepsis?

Among these 19 people:

What is the gender of people who have Enterococcal sepsis when taking Embolex? *

female: 10.53 %
male: 89.47 %

What is the age of people who have Enterococcal sepsis when taking Embolex? *

What are other drugs people take besides Embolex? *

What are other side effects people have besides Enterococcal sepsis? *

Rashes (redness): 18 people, 94.74%
Joint Injury: 17 people, 89.47%
Vasculitis (inflammation of a blood vessel or blood vessels): 2 people, 10.53%
Liver Function Test Abnormal: 2 people, 10.53%
Autoimmune Disorder (a condition in which the immune system attacks the body's normal substances and tissue): 2 people, 10.53%
Drug Hypersensitivity: 2 people, 10.53%
Iucd Complication: 2 people, 10.53%
Abdominal Pain: 2 people, 10.53%
Muscle Haemorrhage (bleeding in muscle): 2 people, 10.53%
Kidney Infection (Pyelonephritis): 1 person, 5.26%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 17 people, 89.47%
Rheumatic Fever (an inflammatory disease that occurs following a streptococcus pyogenes infection): 2 people, 10.53%
Birth Control: 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Embolex and have Enterococcal sepsis?

- Check whether Enterococcal sepsis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Embolex:

Embolex (1,161 reports)

Enterococcal sepsis treatments and more:

Enterococcal sepsis (1,140 reports)

How severe was Enterococcal sepsis and when was it recovered:

Enterococcal sepsis in Embolex

Expand to all the drugs that have ingredients of dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride:

Enterococcal sepsis and drugs with ingredients of dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Embolex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Enterococcal sepsis:

Enterococcal sepsis (191 drugs)

Browse all the conditions that are associated with Enterococcal sepsis:

Enterococcal sepsis (336 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride (the active ingredients of Embolex) and Embolex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.